Utilizing Aspergillus Fungi, a Significant Veterinary Pathogen, in Lung Cancer Treatment: A Novel Approach

Area of Science:

• Mycology
• Pharmacology
• Oncology

Background:

• Cancer remains a major global health challenge requiring novel therapeutic strategies.
• Filamentous Aspergillus molds are increasingly investigated for their potential anti-cancer activities.

Purpose of the Study:

• To systematically review the anti-tumor effects of Aspergillus species and their secondary metabolites on lung cancer.
• To identify promising compounds and understand their mechanisms of action.

Main Methods:

• Literature review of studies on Aspergillus species and their metabolites.
• Analysis of evidence for anti-cancer properties, including cytotoxicity and apoptosis induction.
• Assessment of mechanisms like angiogenesis inhibition and immune modulation.

Main Results:

• Several Aspergillus species (e.g., A. fumigatus, A. nidulans, A. terreus, A. flavus) produce anti-cancer compounds.
• Specific metabolites like gliotoxin, emericellamide A, serotonin, and cyclopiazonic acid show efficacy against lung cancer cells.
• Compounds exhibit diverse anti-cancer effects including apoptosis induction, anti-angiogenesis, and proliferation suppression.

Conclusions:

• Aspergillus fungi represent a valuable source of novel anti-cancer agents for lung cancer treatment.
• Challenges in compound identification, production, and therapeutic integration require collaborative research efforts.
• Further investigation into Aspergillus-derived compounds can expand therapeutic options for lung cancer.